ALPHA TAU MEDICAL news, videos and press releases - Page 2
For more news please use our advanced search feature.
ALPHA TAU MEDICAL - More news...
ALPHA TAU MEDICAL - More news...
- Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial
- Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit
- Alpha Tau Medical Confirms No Direct Exposure to Silicon Valley Bank
- Alpha Tau Medical Announces Full Year 2022 Financial Results and Provides Corporate Update
- Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) Trial
- Alpha Tau Announces Grant of Expanded Radioactive License and Final Pre-Clinical Laboratory Regulatory Approval at its Jerusalem Headquarters
- Alpha Tau Announces Health Canada Authorization for Alpha DaRT Clinical Trial for the Treatment of Liver Metastases
- Alpha Tau to Participate in Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference
- Alpha Tau to Present at Biotech Showcase and Participate in LifeSci Advisors Corporate Access Event During J.P. Morgan Healthcare Conference in San Francisco in January 2023
- Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
- Alpha Tau to Present at Upcoming November Investor Conferences
- Alpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society for Radiation Oncology
- Alpha Tau Announces the Acceptance in Major Peer-Reviewed Journals (International Journal of Radiation Oncology, Biology, Physics, and Frontiers in Oncology) of Two Landmark Pre-Clinical Studies Demonstrating Significant Potential Synergies Between the Alpha DaRT Treatment and Standard-of-Care Immunotherapy, Chemotherapy and Anti-Angiogenic Therapy
- Alpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial Officer
- Alpha Tau Medical to Participate in Upcoming September Investor Conferences
- Alpha Tau Medical Announces Second Quarter 2022 Financial Results and Provides Corporate Update
- Alpha Tau and MIM Software Announce Collaboration for Alpha DaRT Treatment Planning
- Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT Clinical Trials